The global Neuroscience Market size reached USD 35.9 Billion in 2024. It is expected to reach USD 48.0 Billion by 2033, growing at a CAGR of 3.1% from 2025 to 2033. This growth is driven by the rising prevalence of neurological disorders, technological advancements in neuroimaging, growing awareness of mental health, and increased government investments supporting research and development.
STUDY ASSUMPTION YEARS
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
NEUROSCIENCE MARKET KEY TAKEAWAYS
- Current Market Size: USD 35.9 Billion in 2024
- CAGR: 3.1% during 2025-2033
- Forecast Period: 2025-2033
- Increasing funding in R&D by industry and research institutions is accelerating the creation of new treatments.
- The rising occurrence of neurological disorders like epilepsy and Alzheimer’s is significantly propelling demand.
- North America dominates the market with major investments in research and advanced healthcare systems.
- The Asia Pacific region is the fastest growing, supported by government initiatives such as China Brain Project.
- Hospitals are expected to witness the fastest growth among end users due to rising neurological admissions.
Sample Request Link:
https://www.imarcgroup.com/neuroscience-market/requestsample
MARKET GROWTH FACTORS
The growth of the neuroscience market is largely fueled by a surge in funding for research and development (R&D) from both industry players and research institutions. This influx of resources is paving the way for new treatments and technologies aimed at tackling a variety of neurological disorders, including epilepsy. Additionally, governments around the world are stepping up their investments in research and encouraging partnerships between industries and academic institutions, which is significantly boosting market growth.
The increasing number of neurological disorders, such as Alzheimer’s, brain cancer, epilepsy, and Parkinson’s disease, is driving a strong demand for advanced diagnostic and treatment options. For instance, it’s projected that the number of Alzheimer’s cases in the US will hit 13 million by 2050. The global rise in aging populations is also contributing to the heightened need for neuroscience applications and technologies.
Recent technological advancements have greatly enhanced neuroimaging tools like MRI, PET, and EEG, leading to more accurate and faster diagnoses. The incorporation of AI and machine learning algorithms is further improving diagnostic precision, while breakthroughs in neuro-microscopy using ultra-miniature electronic microscopes are expanding our ability to detect and potentially reverse neurological damage. These innovations are vital for pushing forward neuroscience research and clinical practices.
MARKET SEGMENTATION
Breakup by Component:
- Instruments and Consumables
- Software and Services
Instruments and consumables dominate due to demand for advanced diagnostic and surgical tools in medical and research settings. Technological progress in precision instruments and new consumables tailored for molecular and genomic research are key growth drivers._
Breakup by Technology:
- Brain Imaging
- Neuro-Microscopy
- Electrophysiology
- Neuroproteomic Analysis
- Animal Behaviour Analysis
- Others
Brain imaging leads the market, driven by demand for accurate early diagnostic capabilities in neurological disorders like Alzheimer’s and strokes. Advances in MRI, PET, and AI integration enhance resolution and diagnostic efficiency._
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Research and Academic Institutes
- Others
Hospitals lead growth due to increasing neurological admissions and expanded healthcare infrastructure. Diagnostic laboratories grow with demand for early and accurate disease diagnosis. Research institutes contribute through scientific advancements and collaborations.
Breakup by Region:
- Asia Pacific
- Europe
- North America
- Latin America
- Middle East and Africa
North America holds the largest market share owing to the high prevalence of chronic diseases, R&D investments, and the presence of prominent companies. Asia Pacific is the fastest-growing region, aided by increased healthcare spending and major government projects.
REGIONAL INSIGHTS
North America leads the global neuroscience market owing to robust investments in research and development, high prevalence of neurological disorders, and established healthcare infrastructure. The United States hosts leading companies and research bodies driving innovation. The Asia Pacific region is the fastest growing, with significant healthcare expenditures and initiatives like China Brain Project, accelerating neuroscience advancement.
RECENT DEVELOPMENTS & NEWS
- In 2021, Blackrock Neurotech announced a breakthrough with a wireless brain-computer interface (BCI) system allowing real-time neural activity monitoring without wired connections, enhancing patient mobility.
- In 2022, Kernel introduced Kernel Flow, a non-invasive brain recording device using advanced time-domain functional near-infrared spectroscopy (TD-fNIRS) technology, offering high spatial and temporal resolution for research and clinical applications.
KEY PLAYERS
- Alpha Omega Engineering
- Biobserve GmbH
- Blackrock Neurotech
- Doric Lenses Inc.
- General Electric Company
- Kernel
- Laserglow Technologies
- Mightex Systems
- NeuroNexus Technologies Inc.
- Noldus Information Technology B.V.
- Plexon Inc.
- Prizmatix Ltd.
- Siemens AG
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
ABOUT US
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
CONTACT US
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
